Skip to main content

Table 3 General conditions and HBV infection of infants in the 3 groups

From: Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission

 

Group A

Group B

Group C

P

Sujects, n

62

61

65

 

Gestational age, wk

39.1 ± 1.1

39.2 ± 1.2

39.0 ± 1.1

0.613

Weight, g

3465.78 ± 408.5

3475.4 ± 398.4

3468.6 ± 401.3

0.991

Length, cm

50.4 ± 1.1

50.5 ± 1.3

50.6 ± 1.4

0.677

Head circumference, cm

33.5 ± 1.2

33.7 ± 1.1

33.3 ± 1.3

0.179

Apgar score

9.95 ± 0.2

9.97 ± 0.17

9.98 ± 0.18

0.648

HBV infection, n(%)

0

0

12(18.4)

<0.001